Artificial synapse chip interface for electronic prosthetic retina
View Patent ↗The invention provides microfabricated devices and methods for directing the growth of a cell process to form an artificial synapse. The devices are called artificial synapse chips. The artificial synapse comprises a nanofabricated aperture (about 50–100 nm in size) that connects the cell process to a chemical or electrical means of neuronal excitation. Such an aperture width mimics the length scales of a natural synapse and thus emphasizes the localized spatial relationship between a neuron and a stimulation source. The invention further provides devices and methods for regenerating a nerve fiber into an electrode. The invention thus provides a regeneration electrode that uses a novel neural interface for stimulation and that uses novel surface methods for directing neuronal growth making possible in vivo connection of the devices to neural circuitry in a retina and other anatomical locations.
1. An ocular implant, comprising:
(a) a substrate having a surface biocompatible with at least a portion of a cell, said surface having a micropattern to direct the growth of a cell process of said cell;
(b) an aperture in said surface, said aperture capable of receiving said cell process; and
(c) a reservoir containing a fluid connected to said aperture, said aperture providing a conduit for delivery of said fluid from said reservoir to said cell process in said aperture,
wherein said ocular implant is oxidized and coated with a polyimide layer to reduce capacitance.
2. The ocular implant as set forth in claim 1 , wherein said micropattern comprises chemoattractant factors.
3. The ocular implant as set forth in claim 1 , wherein said fluid comprises neuromodulatory agents.
4. The ocular implant as set forth in claim 3 , wherein said neuromodulatory agent are neurotransmitters.
5. The ocular implant as set forth in claim 1 , further comprising an electrical circuit, having at least one contact effective to stimulate at least a portion of said cell process.
6. The ocular implant as set forth in claim 5 , wherein said cell process stimulation is selected from the group consisting of stimulation of a neurite, stimulation of a cell through a neurite, and direct stimulation of a cell.
7. The ocular implant as set forth in claim 1 , wherein said ocular implant is implanted adjacent to the inner limiting membrane or in the subretinal space.
8. The ocular implant as set forth in claim 1 , further comprising a microfluidic device in operable relationship with said fluid in said reservoir.
9. The ocular implant as set forth in claim 8 , wherein said microfluidic device is a mechanical device.
10. The ocular implant as set forth in claim 8 , wherein said microfluidic device is a micro-electro-mechanical device.